New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Rapporten

Verifierade nyheter om finansiering, huvudkontor och ledarskap från världens mest innovativa företag

3 rapporter och fler

Uppdateras dagligen med senaste marknadsintelligens

AdvanCell Raises $315M Series D for Targeted Alpha Therapies

AdvanCell closed an oversubscribed, upsized $315 million Series D led by Ally Bridge Group and co-led by Alpha Wave to advance ADVC001 toward Phase 3 and expand U.S. manufacturing.

AdvanCell Raises $112M in Series C

AdvanCell, a HealthTech company based in San Francisco, CA, has raised $112M in Series C at a $700M valuation led by Deerfield Management, Logos Capital.

Fundraising News Team

AdvanCell raises $112M Series C at $700M valuation

AdvanCell raises $112M in Series C at $700M valuation. Radionuclide cancer therapies...

Editorial Team

Feb 1, 2025

0 min read•$112M

Sida 1

Visar 3 rapporter • Sida 1 • Kategori: all

Ligga steget före marknaden

Få veckovisa insikter levererade till din inkorg. Ingen spam, bara intelligens.